Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Growth 2025-2031
The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.
United States market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) players cover Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Forecast” looks at past sales and reviews total world Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales in 2024, providing a comprehensive analysis by region and market sector of projected Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales for 2025 through 2031. With Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) industry.
This Insight Report provides a comprehensive analysis of the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy).
This report presents a comprehensive overview, market shares, and growth opportunities of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market?
What factors are driving Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market opportunities vary by end market size?
How does Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.
United States market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) players cover Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Forecast” looks at past sales and reviews total world Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales in 2024, providing a comprehensive analysis by region and market sector of projected Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales for 2025 through 2031. With Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) industry.
This Insight Report provides a comprehensive analysis of the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy).
This report presents a comprehensive overview, market shares, and growth opportunities of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Dominant Optic Atrophy
- Recessive Optic Atrophy
- Hospitals
- Eye Clinics
- Medical Research Institute
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alkeus Pharmaceuticals
- Amgen
- Biovista
- Editas Medicine
- GenSight Biologics
- Ixchel Pharma
- Khondrion
- Mitotech
- ProQR Therapeutics
- Sanofi
- Spark Therapeutics
- Stealth BioTherapeutics
- Usher Syndrome
What is the 10-year outlook for the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market?
What factors are driving Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market opportunities vary by end market size?
How does Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country/Region, 2020, 2024 & 2031
2.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type
2.2.1 Dominant Optic Atrophy
2.2.2 Recessive Optic Atrophy
2.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type
2.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
2.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Type (2020-2025)
2.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application
2.4.1 Hospitals
2.4.2 Eye Clinics
2.4.3 Medical Research Institute
2.4.4 Other
2.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application
2.5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Market Share by Application (2020-2025)
2.5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Breakdown Data by Company
3.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales by Company (2020-2025)
3.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Company (2020-2025)
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue by Company (2020-2025)
3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company (2020-2025)
3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company (2020-2025)
3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Company
3.4 Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Location Distribution
3.4.2 Players Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LEBER’S HEREDITARY OPTIC NEUROPATHY (LHON) (LEBER OPTIC ATROPHY) BY GEOGRAPHIC REGION
4.1 World Historic Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Geographic Region (2020-2025)
4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country/Region (2020-2025)
4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
4.4 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
4.5 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
4.6 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
5 AMERICAS
5.1 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
5.1.1 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025)
5.1.2 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025)
5.2 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
5.3 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
6.1.1 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2020-2025)
6.1.2 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2020-2025)
6.2 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
6.3 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
7.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025)
7.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025)
7.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
7.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
8.1.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025)
8.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
8.3 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
10.3 Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
10.4 Industry Chain Structure of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
11.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customer
12 WORLD FORECAST REVIEW FOR LEBER’S HEREDITARY OPTIC NEUROPATHY (LHON) (LEBER OPTIC ATROPHY) BY GEOGRAPHIC REGION
12.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Region
12.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecast by Region (2026-2031)
12.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecast by Type (2026-2031)
12.7 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Alkeus Pharmaceuticals
13.1.1 Alkeus Pharmaceuticals Company Information
13.1.2 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alkeus Pharmaceuticals Main Business Overview
13.1.5 Alkeus Pharmaceuticals Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Biovista
13.3.1 Biovista Company Information
13.3.2 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biovista Main Business Overview
13.3.5 Biovista Latest Developments
13.4 Editas Medicine
13.4.1 Editas Medicine Company Information
13.4.2 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Editas Medicine Main Business Overview
13.4.5 Editas Medicine Latest Developments
13.5 GenSight Biologics
13.5.1 GenSight Biologics Company Information
13.5.2 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GenSight Biologics Main Business Overview
13.5.5 GenSight Biologics Latest Developments
13.6 Ixchel Pharma
13.6.1 Ixchel Pharma Company Information
13.6.2 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ixchel Pharma Main Business Overview
13.6.5 Ixchel Pharma Latest Developments
13.7 Khondrion
13.7.1 Khondrion Company Information
13.7.2 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Khondrion Main Business Overview
13.7.5 Khondrion Latest Developments
13.8 Mitotech
13.8.1 Mitotech Company Information
13.8.2 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mitotech Main Business Overview
13.8.5 Mitotech Latest Developments
13.9 ProQR Therapeutics
13.9.1 ProQR Therapeutics Company Information
13.9.2 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 ProQR Therapeutics Main Business Overview
13.9.5 ProQR Therapeutics Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Spark Therapeutics
13.11.1 Spark Therapeutics Company Information
13.11.2 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Spark Therapeutics Main Business Overview
13.11.5 Spark Therapeutics Latest Developments
13.12 Stealth BioTherapeutics
13.12.1 Stealth BioTherapeutics Company Information
13.12.2 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Stealth BioTherapeutics Main Business Overview
13.12.5 Stealth BioTherapeutics Latest Developments
13.13 Usher Syndrome
13.13.1 Usher Syndrome Company Information
13.13.2 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Usher Syndrome Main Business Overview
13.13.5 Usher Syndrome Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country/Region, 2020, 2024 & 2031
2.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type
2.2.1 Dominant Optic Atrophy
2.2.2 Recessive Optic Atrophy
2.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type
2.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
2.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Type (2020-2025)
2.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application
2.4.1 Hospitals
2.4.2 Eye Clinics
2.4.3 Medical Research Institute
2.4.4 Other
2.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application
2.5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Market Share by Application (2020-2025)
2.5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Breakdown Data by Company
3.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales by Company (2020-2025)
3.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Company (2020-2025)
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue by Company (2020-2025)
3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company (2020-2025)
3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company (2020-2025)
3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Company
3.4 Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Location Distribution
3.4.2 Players Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LEBER’S HEREDITARY OPTIC NEUROPATHY (LHON) (LEBER OPTIC ATROPHY) BY GEOGRAPHIC REGION
4.1 World Historic Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Geographic Region (2020-2025)
4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country/Region (2020-2025)
4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
4.4 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
4.5 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
4.6 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth
5 AMERICAS
5.1 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
5.1.1 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025)
5.1.2 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025)
5.2 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
5.3 Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
6.1.1 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2020-2025)
6.1.2 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2020-2025)
6.2 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
6.3 APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
7.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025)
7.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025)
7.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
7.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
8.1.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025)
8.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025)
8.3 Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
10.3 Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
10.4 Industry Chain Structure of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
11.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customer
12 WORLD FORECAST REVIEW FOR LEBER’S HEREDITARY OPTIC NEUROPATHY (LHON) (LEBER OPTIC ATROPHY) BY GEOGRAPHIC REGION
12.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Region
12.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecast by Region (2026-2031)
12.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecast by Type (2026-2031)
12.7 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Alkeus Pharmaceuticals
13.1.1 Alkeus Pharmaceuticals Company Information
13.1.2 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alkeus Pharmaceuticals Main Business Overview
13.1.5 Alkeus Pharmaceuticals Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Biovista
13.3.1 Biovista Company Information
13.3.2 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biovista Main Business Overview
13.3.5 Biovista Latest Developments
13.4 Editas Medicine
13.4.1 Editas Medicine Company Information
13.4.2 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Editas Medicine Main Business Overview
13.4.5 Editas Medicine Latest Developments
13.5 GenSight Biologics
13.5.1 GenSight Biologics Company Information
13.5.2 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GenSight Biologics Main Business Overview
13.5.5 GenSight Biologics Latest Developments
13.6 Ixchel Pharma
13.6.1 Ixchel Pharma Company Information
13.6.2 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ixchel Pharma Main Business Overview
13.6.5 Ixchel Pharma Latest Developments
13.7 Khondrion
13.7.1 Khondrion Company Information
13.7.2 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Khondrion Main Business Overview
13.7.5 Khondrion Latest Developments
13.8 Mitotech
13.8.1 Mitotech Company Information
13.8.2 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mitotech Main Business Overview
13.8.5 Mitotech Latest Developments
13.9 ProQR Therapeutics
13.9.1 ProQR Therapeutics Company Information
13.9.2 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 ProQR Therapeutics Main Business Overview
13.9.5 ProQR Therapeutics Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Spark Therapeutics
13.11.1 Spark Therapeutics Company Information
13.11.2 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Spark Therapeutics Main Business Overview
13.11.5 Spark Therapeutics Latest Developments
13.12 Stealth BioTherapeutics
13.12.1 Stealth BioTherapeutics Company Information
13.12.2 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Stealth BioTherapeutics Main Business Overview
13.12.5 Stealth BioTherapeutics Latest Developments
13.13 Usher Syndrome
13.13.1 Usher Syndrome Company Information
13.13.2 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
13.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Usher Syndrome Main Business Overview
13.13.5 Usher Syndrome Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dominant Optic Atrophy
Table 4. Major Players of Recessive Optic Atrophy
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2020-2025) & ($ million)
Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2020-2025)
Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Type (2020-2025) & (USD/Piece)
Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Market Share by Application (2020-2025)
Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2020-2025)
Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Application (2020-2025) & (USD/Piece)
Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Company (2020-2025)
Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company (2020-2025)
Table 19. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Company (2020-2025) & (USD/Piece)
Table 20. Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Producing Area Distribution and Sales Area
Table 21. Players Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
Table 22. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2020-2025)
Table 35. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2020-2025)
Table 40. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Table 52. Key Market Challenges & Risks of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Table 53. Key Industry Trends of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Table 54. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 57. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customer List
Table 58. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Alkeus Pharmaceuticals Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 73. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 74. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 75. Alkeus Pharmaceuticals Main Business
Table 76. Alkeus Pharmaceuticals Latest Developments
Table 77. Amgen Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 78. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 79. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Biovista Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 83. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 84. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 85. Biovista Main Business
Table 86. Biovista Latest Developments
Table 87. Editas Medicine Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 88. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 89. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 90. Editas Medicine Main Business
Table 91. Editas Medicine Latest Developments
Table 92. GenSight Biologics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 93. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 94. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 95. GenSight Biologics Main Business
Table 96. GenSight Biologics Latest Developments
Table 97. Ixchel Pharma Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 98. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 99. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 100. Ixchel Pharma Main Business
Table 101. Ixchel Pharma Latest Developments
Table 102. Khondrion Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 103. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 104. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 105. Khondrion Main Business
Table 106. Khondrion Latest Developments
Table 107. Mitotech Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 108. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 109. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 110. Mitotech Main Business
Table 111. Mitotech Latest Developments
Table 112. ProQR Therapeutics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 113. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 114. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 115. ProQR Therapeutics Main Business
Table 116. ProQR Therapeutics Latest Developments
Table 117. Sanofi Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 118. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 119. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 120. Sanofi Main Business
Table 121. Sanofi Latest Developments
Table 122. Spark Therapeutics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 123. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 124. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 125. Spark Therapeutics Main Business
Table 126. Spark Therapeutics Latest Developments
Table 127. Stealth BioTherapeutics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 128. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 129. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 130. Stealth BioTherapeutics Main Business
Table 131. Stealth BioTherapeutics Latest Developments
Table 132. Usher Syndrome Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 133. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 134. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 135. Usher Syndrome Main Business
Table 136. Usher Syndrome Latest Developments
Table 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dominant Optic Atrophy
Table 4. Major Players of Recessive Optic Atrophy
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2020-2025) & ($ million)
Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2020-2025)
Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Type (2020-2025) & (USD/Piece)
Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Market Share by Application (2020-2025)
Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2020-2025)
Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Application (2020-2025) & (USD/Piece)
Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Company (2020-2025)
Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company (2020-2025)
Table 19. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Price by Company (2020-2025) & (USD/Piece)
Table 20. Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Producing Area Distribution and Sales Area
Table 21. Players Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
Table 22. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2020-2025)
Table 35. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2020-2025)
Table 40. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Table 52. Key Market Challenges & Risks of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Table 53. Key Industry Trends of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Table 54. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 57. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customer List
Table 58. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Alkeus Pharmaceuticals Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 73. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 74. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 75. Alkeus Pharmaceuticals Main Business
Table 76. Alkeus Pharmaceuticals Latest Developments
Table 77. Amgen Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 78. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 79. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Biovista Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 83. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 84. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 85. Biovista Main Business
Table 86. Biovista Latest Developments
Table 87. Editas Medicine Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 88. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 89. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 90. Editas Medicine Main Business
Table 91. Editas Medicine Latest Developments
Table 92. GenSight Biologics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 93. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 94. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 95. GenSight Biologics Main Business
Table 96. GenSight Biologics Latest Developments
Table 97. Ixchel Pharma Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 98. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 99. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 100. Ixchel Pharma Main Business
Table 101. Ixchel Pharma Latest Developments
Table 102. Khondrion Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 103. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 104. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 105. Khondrion Main Business
Table 106. Khondrion Latest Developments
Table 107. Mitotech Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 108. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 109. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 110. Mitotech Main Business
Table 111. Mitotech Latest Developments
Table 112. ProQR Therapeutics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 113. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 114. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 115. ProQR Therapeutics Main Business
Table 116. ProQR Therapeutics Latest Developments
Table 117. Sanofi Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 118. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 119. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 120. Sanofi Main Business
Table 121. Sanofi Latest Developments
Table 122. Spark Therapeutics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 123. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 124. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 125. Spark Therapeutics Main Business
Table 126. Spark Therapeutics Latest Developments
Table 127. Stealth BioTherapeutics Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 128. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 129. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 130. Stealth BioTherapeutics Main Business
Table 131. Stealth BioTherapeutics Latest Developments
Table 132. Usher Syndrome Basic Information, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base, Sales Area and Its Competitors
Table 133. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolios and Specifications
Table 134. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue ($ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 135. Usher Syndrome Main Business
Table 136. Usher Syndrome Latest Developments
LIST OF FIGURES
Figure 1. Picture of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 2. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country/Region (2024)
Figure 10. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Dominant Optic Atrophy
Figure 12. Product Picture of Recessive Optic Atrophy
Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type in 2025
Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2020-2025)
Figure 15. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Hospitals
Figure 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Hospitals (2020-2025) & (K Pcs)
Figure 17. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Eye Clinics
Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Eye Clinics (2020-2025) & (K Pcs)
Figure 19. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Medical Research Institute
Figure 20. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Medical Research Institute (2020-2025) & (K Pcs)
Figure 21. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Other
Figure 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Other (2020-2025) & (K Pcs)
Figure 23. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Market Share by Application (2024)
Figure 24. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application in 2025
Figure 25. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Company in 2025 (K Pcs)
Figure 26. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Company in 2025
Figure 27. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company in 2025 ($ millions)
Figure 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company in 2025
Figure 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 32. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 33. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 34. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 35. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 36. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 39. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country in 2025
Figure 40. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2020-2025)
Figure 41. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 42. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 43. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region in 2025
Figure 48. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2020-2025)
Figure 49. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 50. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 51. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 55. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country in 2025
Figure 59. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2020-2025)
Figure 60. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 61. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 62. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 63. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 70. Egypt Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in 2025
Figure 76. Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 77. Industry Chain Structure of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 78. Channels of Distribution
Figure 79. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Forecast by Region (2026-2031)
Figure 80. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 2. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country/Region (2024)
Figure 10. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Dominant Optic Atrophy
Figure 12. Product Picture of Recessive Optic Atrophy
Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type in 2025
Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2020-2025)
Figure 15. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Hospitals
Figure 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Hospitals (2020-2025) & (K Pcs)
Figure 17. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Eye Clinics
Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Eye Clinics (2020-2025) & (K Pcs)
Figure 19. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Medical Research Institute
Figure 20. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Medical Research Institute (2020-2025) & (K Pcs)
Figure 21. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Consumed in Other
Figure 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Other (2020-2025) & (K Pcs)
Figure 23. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sale Market Share by Application (2024)
Figure 24. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application in 2025
Figure 25. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Company in 2025 (K Pcs)
Figure 26. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Company in 2025
Figure 27. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company in 2025 ($ millions)
Figure 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company in 2025
Figure 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 32. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 33. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 34. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 35. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 36. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2020-2025 ($ millions)
Figure 39. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country in 2025
Figure 40. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2020-2025)
Figure 41. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 42. Americas Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 43. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region in 2025
Figure 48. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2020-2025)
Figure 49. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 50. APAC Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 51. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 55. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country in 2025
Figure 59. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2020-2025)
Figure 60. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 61. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 62. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 63. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2020-2025)
Figure 70. Egypt Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in 2025
Figure 76. Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 77. Industry Chain Structure of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 78. Channels of Distribution
Figure 79. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Forecast by Region (2026-2031)
Figure 80. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Malignant Glioma Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
85 pages
Global Hydrolyzed Bovine Collagen Market Growth 2025-2031
US$ 3,660.00
December 2025
78 pages
Global Q-Switching Laser Technologies Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
113 pages
